Search Results

SB 239063 5 mg  | 99.81%

TargetMol

SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.

More Information Supplier Page

Chlorprothixene 100 mg  | 99.69%

TargetMol

Chlorprothixene is a typical antipsychotic drug of the thioxanthene class, which was the first of the series to be synthesized.

More Information Supplier Page

Chlorprothixene 200 mg  | 99.69%

TargetMol

Chlorprothixene is a typical antipsychotic drug of the thioxanthene class, which was the first of the series to be synthesized.

More Information Supplier Page

Domperidone 100 mg  | Purity Not Available

TargetMol

Domperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent. It blocks the action of. It has strong affinities for the D2 and D3 dopamine receptors, which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which – among others – regulates nausea and vomiting (area postrema on the floor of […]

More Information Supplier Page

Domperidone 200 mg  | Purity Not Available

TargetMol

Domperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent. It blocks the action of. It has strong affinities for the D2 and D3 dopamine receptors, which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which – among others – regulates nausea and vomiting (area postrema on the floor of […]

More Information Supplier Page

Mirtazapine 10 mg  | 99.30%

TargetMol

Mirtazapine is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Zalcitabine 200 mg  | 98.00%

TargetMol

Zalcitabine(Dideoxycytidine;ddC; 2′, 3′-Dideoxycytidine) is a nucleoside analog reverse transcriptase inhibitor (NRTI); At low concentrations, It can potently inhibit HIV replication by binding to reverse transcriptase terminated synthesis of viral DNA chain.

More Information Supplier Page

Zalcitabine 50 mg  | 98.00%

TargetMol

Zalcitabine(Dideoxycytidine;ddC; 2′, 3′-Dideoxycytidine) is a nucleoside analog reverse transcriptase inhibitor (NRTI); At low concentrations, It can potently inhibit HIV replication by binding to reverse transcriptase terminated synthesis of viral DNA chain.

More Information Supplier Page